Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06415799 · ClinicalTrials.gov registry record
OM2 Abbreviated Sensor Verification
A clinical trial of Hypoxia, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT06415799: Completed study of Hypoxia, sponsored by Medtronic - MITG.
NCT06415799 is a study of Hypoxia that has completed, run by Medtronic - MITG. The registered enrollment target is 28 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06415799, a study of Hypoxia, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.
Primary Outcome
Acceptance criteria for * SpO2 across the saturation range of 70-100% * Pulse rate from 20-250 BPM
Conditions Studied
Study Locations (1)
Colorado
- Element - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2024-02-11 |
| Est. Completion | 2024-02-22 |
What the finished NCT06415799 record still lists
NCT06415799 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 0 interventions.
NCT06415799 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06415799 about?
NCT06415799 is a clinical study titled "OM2 Abbreviated Sensor Verification". The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.
What is the current status of trial NCT06415799?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2024-02-11. Estimated completion is 2024-02-22.
What conditions does trial NCT06415799 study?
This clinical trial studies the following conditions: Hypoxia.
Who is sponsoring clinical trial NCT06415799?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06415799 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06415799's enrollment target sits among peer trials
28 22nd of 39 higher than 18 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI